Entera Bio Ltd.
ENTX
$2.06
-$0.16-7.21%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.93% | -23.82% | -27.27% | -18.20% | -26.99% |
| Total Depreciation and Amortization | -27.27% | -36.36% | -38.46% | -15.38% | -21.43% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -3.33% | -10.46% | 31.87% | 73.08% | 134.17% |
| Change in Net Operating Assets | -177.63% | 136.41% | 277.32% | 130.32% | -117.19% |
| Cash from Operations | -16.16% | -22.17% | 24.60% | 43.94% | -41.25% |
| Capital Expenditure | -- | -- | -- | 40.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 40.00% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1,830.77% | -98.06% | 44,976.67% | -46.45% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -294.74% | -- | 44.31% | -- |
| Cash from Financing | 1,823.08% | -104.19% | 44,356.67% | -46.66% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.84% | -1,337.82% | 750.93% | -48.75% | -40.39% |